ABCG2 and central nervous system cancer: Taken together, these data demonstrated that knockdown of lncRNA CRNDE could enhance chemosensitivity to TMZ, inhibit cell viability, decrease cell proliferation, facilitate cell apoptosis, and reduce the expression of ABCG2 in glioma cells.